A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19

Comment on “Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19” published inJAMA (doi:10.1001/jama.2020.25864)
Source: European Heart Journal - Category: Cardiology Source Type: research